Fidia Farmaceutici S.P.A.
Fidia Farmaceutici S.P.A., a prominent player in the pharmaceutical industry, is headquartered in Italy and operates extensively across Europe and beyond. Founded in 1946, the company has established itself as a leader in the development of innovative treatments, particularly in the fields of orthopaedics, rheumatology, and gynaecology. Fidia is renowned for its unique hyaluronic acid-based products, which are designed to enhance patient care and improve quality of life. With a strong commitment to research and development, the company has achieved significant milestones, including the introduction of groundbreaking therapies that address unmet medical needs. Fidia's dedication to excellence has positioned it as a trusted name in the pharmaceutical sector, recognised for its contributions to healthcare and its ongoing pursuit of innovation.
DitchCarbon Score
How does Fidia Farmaceutici S.P.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fidia Farmaceutici S.P.A.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Fidia Farmaceutici S.P.A.'s reported carbon emissions
Fidia Farmaceutici S.P.A., headquartered in Italy, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is classified as a current subsidiary and does not inherit emissions data from a parent organization. In terms of climate commitments, there are no documented reduction targets or initiatives such as Science-Based Targets (SBTi) or other climate pledges. This lack of data suggests that Fidia Farmaceutici S.P.A. may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the pharmaceutical industry increasingly focuses on sustainability, Fidia Farmaceutici S.P.A. may benefit from establishing clear emissions reduction goals and participating in recognised climate initiatives to enhance its environmental performance and transparency.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Fidia Farmaceutici S.P.A. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
